|Project Title||ARIA Tool Enhancement: Enabling Interrupted Time Series Analyses|
Wednesday, December 5, 2018
The aim of this methods project is to make major enhancements to the Active Risk Identification and Analysis (ARIA) tool in order to develop the capability to evaluate the effects of FDA regulatory actions. This will be accomplished by enabling comparisons of outcomes in pre- vs. post-intervention periods.
Christine Lu MSc, PhD, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
Jolene Damon MPH; Sandra DeLuccia MPH; April Duddy MPH; Jenny Hochstadt MSc, MSW; Laura Hou MS, MPH; Joy Kolonoski MPH; Ella Pestine MPH; Andrew Petrone MPH; Rong Chen Tilney MS; Justin Vigeant; Fang Zhang PhD; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
- Vaccines, Blood & Biologics
- Devices and Radiologic Health